Human epidermal growth factor 2 (HER2) encodes a 185 kDa transmembrane tyrosine kinase, and overexpression of the HER2 gene is associated with poor prognosis in a variety of human cancers, such as breast, ovarian, and lung cancers (10). This evidence concerns the gene ERBB2 and cancer.